Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 2,029-2,040 of 6,115
Drug study icon
Not recruitingISRCTN06123818

lymphocyte neurotransmitter markers in depression and anxiety

This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.

In Venezuela
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyOtherOver 18 Years
Countries
Venezuela
Sponsor
Venezuelan Institute of Scientific Investigations (Instituto Venezolano de Investigaciones Científicas) (Venezuela)
Condition
Depression, Anxiety
Drug study icon
Not recruitingISRCTN23577151

The EFFECT-Dep study: Enhancing the effectiveness of electroconvulsive therapy in severe depression

This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.

In Ireland
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
Ireland
Sponsor
St Patrick's Hospital (Ireland)
Condition
Depression
Drug study icon
Not recruitingISRCTN47431149

Treating Depression with Omega-3

This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.

In Canada
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
Canada
Sponsor
University Hospital of Montreal (CHUM) Research Centre (Canada)
Condition
Depression
Drug study icon
SuspendedEUCTR 2010-024371-12

A multicenter, Double-blind 58 week Rollover Study to assess the Safety and Tolerability of BMS-820836 in Patients with Treatment Resistant Major Depression.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
United Kingdom, Austria, Finland, ...
Sponsor
Bristol-Myers Squibb International Corporation
Condition
Depression
Drug study icon
CompletedEUCTR 2010-022841-93

A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients with Treatment Resistant Major Depression Revised protocol ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Finland, Sweden
Sponsor
Bristol-Myers Squibb International Corporation
Condition
Depression
Behavioral study icon
TerminatedISRCTN17534191

Effectiveness of brief cognitive behavioural therapy in depression

This study was terminated in the United Kingdom. It is testing brief cognitive behavioural therapy for depression.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
United Kingdom
Sponsor
Department of Health (UK)
Condition
Depression
Drug study icon
CompletedEUCTR 2009-011990-34

Cytokines and Inflammatory Marker during Therapy in Major Depression with Celecoxib

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Austria, Germany
Sponsor
Clinic for Psychiatry and Psychotherapy of the Ludwig Maximilian University
Condition
Depression
Drug study icon
CompletedEUCTR 2005-001544-23

Hypericum-Extrakt Ze 117 (Zeller AG): Klinische Studie zur Verminderung von Rückfällen bei Patienten mit Depression nach DSM-IV (Mittelschwere Major Depression: einzeln/rezi- divierend)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Germany
Sponsor
Max Zeller Söhne AG
Condition
Depression
Other study type icon
TerminatedISRCTN65803720

LIVELIFE: effectiveness of two types of support for low mood

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyOther
Countries
United Kingdom
Sponsor
University of Exeter (UK)
Condition
Depression, Anxiety
Drug study icon
CompletedEUCTR 2006-006576-38

Longitudinal imaging of serotonin transporter occupancy using PET and [11C]DASB in patients with major depression treated with escitalopram or citalopram

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Austria
Sponsor
Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien
Condition
Depression
Drug study icon
Active Not RecruitingEUCTR 2020-001592-33

Maternal Mental Health (MAMA) Study. Short time estrogen as a candidate strategy to prevent postpartum depression in a high-risk group

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Copenhagen Oe
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Denmark
Sponsor
Rigshospitalet
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.